Stable Istotope Labelled Indusatumab Biosimilar – Anti-GUCY2C mAb – Research Grade

Reference: PX-TA1379-SIL-1MG
Product nameStable Istotope Labelled Indusatumab Biosimilar - Anti-GUCY2C mAb - Research Grade
SourceCAS 1497400-26-6
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /Synonyms5F9,MLN2045
ReferencePX-TA1379-SIL
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-GUCY2C[Homo sapiens] (Indusatumab ) Monoclonal Antibody

Indusatumab has been invetigated for the treatment of Pancreatic Adenocarcinoma, Adenocarcinoma of the Stomach, Recurrent Gastric Adenocarcinoma, Metastatic Gastric Adenocarcinoma, and Advanced Gastrointestinal Carcinoma.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Indusatumab Biosimilar – Anti-GUCY2C mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below